https://deepanalyst.ai/tags/MRNA/Recent content in MRNA on Deep Analyst AIHugo -- gohugo.ioen-usWed, 04 Mar 2026 00:00:00 +0000https://deepanalyst.ai/posts/2026/03/mrna-anatomy-biotech-bipolar-market-moderna-s-costly-surge-merck-s-boom-50-crash-reality/Wed, 04 Mar 2026 00:00:00 +0000https://deepanalyst.ai/posts/2026/03/mrna-anatomy-biotech-bipolar-market-moderna-s-costly-surge-merck-s-boom-50-crash-reality/Anatomy of a Biotech Bipolar Market: Moderna’s Costly Surge, Merck’s Boom, and the 50% Crash Reality Somewhere in the market, a sudden biotech stock crashes 50%-plus scenario just wiped out another portfolio, leaving retail traders traumatized. Yet, look elsewhere, and the narrative flips to sheer speculative mania. We are tracking two massive viral keyword “surge” events breaking the internet today: Moderna (MRNA) miraculously surging after hours on a brutal patent settlement with Arbutus and Genevant, and Merck (MRK), whose juggernaut drug Keytruda continues to drive its 2025 revenue surge.